Literature DB >> 28582468

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.

J Mwinyi, A Boström, I Fehrer, A Othman, G Waeber, H Marti-Soler, P Vollenweider, P Marques-Vidal, H B Schiöth, A von Eckardstein, T Hornemann.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0175776.].

Entities:  

Year:  2017        PMID： 28582468      PMCID： PMC5459559          DOI： 10.1371/journal.pone.0179313

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


  1 in total

1.  Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.

Authors:  J Mwinyi; A Boström; I Fehrer; A Othman; G Waeber; H Marti-Soler; P Vollenweider; P Marques-Vidal; H B Schiöth; A von Eckardstein; T Hornemann
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240
  1 in total
  3 in total

1.  Analysis of sphingolipid composition in human vitreous from control and diabetic individuals.

Authors:  Lynda A Wilmott; Richard C Grambergs; Jeremy C Allegood; Timothy J Lyons; Nawajes Mandal
Journal:  J Diabetes Complications       Date:  2018-12-14       Impact factor: 2.852

2.  Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity.

Authors:  V Fridman; S Zarini; S Sillau; K Harrison; B C Bergman; E L Feldman; J E B Reusch; B C Callaghan
Journal:  J Diabetes Complications       Date:  2021-01-09       Impact factor: 2.852

3.  Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1.

Authors:  Vera Fridman; Saranya Suriyanarayanan; Peter Novak; William David; Eric A Macklin; Diane McKenna-Yasek; Kailey Walsh; Razina Aziz-Bose; Anne Louise Oaklander; Robert Brown; Thorsten Hornemann; Florian Eichler
Journal:  Neurology       Date:  2019-01-09       Impact factor: 9.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.